Fulcrum Therapeutics (FULC) Change in Cash (2019 - 2026)
Fulcrum Therapeutics (FULC) has disclosed Change in Cash for 7 consecutive years, with $150.5 million as the latest value for Q4 2025.
- Quarterly Change in Cash rose 1143.52% to $150.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $139.3 million through Dec 2025, up 325.3% year-over-year, with the annual reading at $139.3 million for FY2025, 325.3% up from the prior year.
- Change in Cash for Q4 2025 was $150.5 million at Fulcrum Therapeutics, up from $4.5 million in the prior quarter.
- The five-year high for Change in Cash was $150.5 million in Q4 2025, with the low at -$55.8 million in Q4 2022.
- Average Change in Cash over 5 years is $7.0 million, with a median of -$566000.0 recorded in 2023.
- Peak annual rise in Change in Cash hit 6189.58% in 2024, while the deepest fall reached 262.51% in 2024.
- Over 5 years, Change in Cash stood at -$30.1 million in 2021, then plummeted by 85.76% to -$55.8 million in 2022, then soared by 91.91% to -$4.5 million in 2023, then plummeted by 219.19% to -$14.4 million in 2024, then surged by 1143.52% to $150.5 million in 2025.
- According to Business Quant data, Change in Cash over the past three periods came in at $150.5 million, $4.5 million, and $414000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.